This resource outlines what antimicrobial resistance (AMR) is, and how we need to limit our use of antimicrobials – such as antibiotics, antivirals, antifungals and antiparasitics – to reduce the risk of drug-resistant infections and impact of AMR.

AURA 2023: Fifth Australian Report on Antimicrobial Use and Resistance in Human Health was released on 16 November 2023, highlighting data trends and analyses across acute and community care settings. 

This A4 infographic showcases key data highlights from AURA 2023 on antimicrobial use in Australia.

This issue includes items on governance and leadership, nursing care, digital health, COVID-19 and more.

Also covered are the latest issues of The Journal for Healthcare Quality, Health Affairs Scholar, Health Affairs and Health Expectations along with early online papers from BMJ Quality & Safety and International Journal for Quality in Health Care and the latest from USA’s AHRQ and CDC.

This fact sheet highlights key findings from AURA 2023 and priorities for action to support primary care services and clinicians prevent and control antimicrobial resistance (AMR) and improve antimicrobial use.

This fact sheet highlights key findings from AURA 2023 and information about antimicrobial stewardship (AMS) and antimicrobial resistance (AMR), to support pharmacists working across primary and acute care settings.

This fact sheet highlights key findings from AURA 2023 and priorities for action to support infection prevention and control clinicians prevent and control antimicrobial resistance (AMR) and improve antimicrobial use.

This fact sheet highlights key findings from AURA 2023 and priorities for action to support aged care services and clinicians prevent and control antimicrobial resistance (AMR) and improve antimicrobial use.